2017 - Yi Qu

Born 1981 in China, has an M.S. in medicine from Peking Union Medical College. In 2013 she gained a PhD from UiB, focused on the generation of a stepwise prostate carcinogenesis model, a study of epithelial-to-mesenchymal transition and malignant transformation of prostate primary epithelial cells. Until 2017, she was a postdoc in the Kalland group, with research focus is on Wnt-related cancerdrug screening and development.